193 related articles for article (PubMed ID: 18344624)
1. Functional polymorphism of the myeloperoxidase gene in hypertensive nephrosclerosis dialysis patients.
Doi K; Noiri E; Maeda R; Nakao A; Kobayashi S; Tokunaga K; Fujita T
Hypertens Res; 2007 Dec; 30(12):1193-8. PubMed ID: 18344624
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation of myeloperoxidase gene contributes to atopic asthma susceptibility: a preliminary association study in Russian population.
Polonikov AV; Solodilova MA; Ivanov VP
J Asthma; 2009 Jun; 46(5):523-8. PubMed ID: 19544176
[TBL] [Abstract][Full Text] [Related]
3. Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy.
Buraczynska K; Koziol-Montewka M; Majdan M; Tokarz A; Ksiazek A
Ren Fail; 2004 Nov; 26(6):633-9. PubMed ID: 15600254
[TBL] [Abstract][Full Text] [Related]
4. The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes.
Mäkelä R; Loimaala A; Nenonen A; Mercuri M; Vuori I; Huhtala H; Oja P; Bond G; Koivula T; Lehtimäki T
Clin Biochem; 2008 May; 41(7-8):532-7. PubMed ID: 18280811
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population.
Park JH; Park JM; Kim EJ; Cha SI; Lee EB; Kim CH; Kam S; Jung TH; Park JY
Cancer Detect Prev; 2006; 30(3):257-61. PubMed ID: 16844322
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis.
Buraczynska M; Jozwiak L; Ksiazek P; Borowicz E; Mierzicki P
Transl Res; 2007 Aug; 150(2):101-5. PubMed ID: 17656329
[TBL] [Abstract][Full Text] [Related]
7. Relation of myeloperoxidase promoter polymorphism and long-term hormone replacement therapy to oxidized low-density lipoprotein autoantibodies in postmenopausal women.
Mäkelä R; Dastidar P; Jokela H; Jaakkola O; Saarela M; Punnonen R; Lehtimäki T
Scand J Clin Lab Invest; 2006; 66(5):371-83. PubMed ID: 16901848
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase (MPO) -463G->A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers.
Van Schooten FJ; Boots AW; Knaapen AM; Godschalk RW; Maas LM; Borm PJ; Drent M; Jacobs JA
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):828-33. PubMed ID: 15159316
[TBL] [Abstract][Full Text] [Related]
9. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
[TBL] [Abstract][Full Text] [Related]
10. Association of myeloperoxidase G-463A gene polymorphism with diabetic nephropathy in Japanese type 2 diabetic subjects.
Katakami N; Kume S; Kaneto H; Uzu T; Kashiwagi A; Yamasaki Y; Maegawa H; Shimomura I
Endocr J; 2013; 60(4):457-71. PubMed ID: 23268804
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of tumor necrosis factor and myeloperoxidase genes in patients with chronic renal failure on peritoneal dialysis.
Buraczynska K; Koziol-Montewka M; Majdan M; Ksiazek A
Mol Diagn; 2003; 7(3-4):175-80. PubMed ID: 15068388
[TBL] [Abstract][Full Text] [Related]
12. The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies.
Chu H; Wang M; Wang M; Gu D; Wu D; Zhang Z; Tang J; Zhang Z
Mutagenesis; 2010 Jul; 25(4):389-95. PubMed ID: 20418356
[TBL] [Abstract][Full Text] [Related]
13. A myeloperoxidase promoter polymorphism is independently associated with mortality in patients with impaired left ventricular function.
Rudolph V; Rudolph TK; Kubala L; Clauberg N; Maas R; Pekarova M; Klinke A; Lau D; Szöcs K; Meinertz T; Böger RH; Baldus S
Free Radic Biol Med; 2009 Dec; 47(11):1584-90. PubMed ID: 19735726
[TBL] [Abstract][Full Text] [Related]
14. The -463G/A polymorphism in myeloperoxidase gene and cervical cancer.
Mustea A; Heinze G; Sehouli J; Koensgen D; Wolf A; Gutu L; Sofroni D; Pirvulescu C; Braicu EI; Schuster E; Zeillinger R; Tong D
Anticancer Res; 2007; 27(3B):1531-5. PubMed ID: 17595772
[TBL] [Abstract][Full Text] [Related]
15. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.
Aker S; Bantis C; Reis P; Kuhr N; Schwandt C; Grabensee B; Heering P; Ivens K
Nephrol Dial Transplant; 2009 Sep; 24(9):2847-51. PubMed ID: 19349293
[TBL] [Abstract][Full Text] [Related]
16. Plasma myeloperoxidase level and peripheral arterial disease.
Haslacher H; Perkmann T; Gruenewald J; Exner M; Endler G; Scheichenberger V; Wagner O; Schillinger M
Eur J Clin Invest; 2012 May; 42(5):463-9. PubMed ID: 21950958
[TBL] [Abstract][Full Text] [Related]
17. Impact of endothelin-1 Lys198Asn polymorphism on coronary artery disease and endorgan damage in hypertensives.
Popov AF; Schulz EG; Hinz J; Schmitto JD; Seipelt R; Koziolek MJ; Rosenberger A; Schoendube FA; Müller GA
Coron Artery Dis; 2008 Nov; 19(7):429-34. PubMed ID: 18923236
[TBL] [Abstract][Full Text] [Related]
18. Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms.
Hoy A; Trégouët D; Leininger-Muller B; Poirier O; Maurice M; Sass C; Siest G; Tiret L; Visvikis S
Eur J Hum Genet; 2001 Oct; 9(10):780-6. PubMed ID: 11781690
[TBL] [Abstract][Full Text] [Related]
19. Platelet GP IIIA polymorphism HPA-1 (PLA1/2) is associated with hypertension as the primary cause for end-stage renal disease in hemodialysis patients from Greece.
Chiras T; Papadakis ED; Katopodi A; Chatzianesti E; Fourtounas K; Papakonstantinou S; Theodoropoulos I; Dakouras A; Zerefos N; Valis D; Tzanatos-Exarchou H
In Vivo; 2009; 23(1):177-81. PubMed ID: 19368146
[TBL] [Abstract][Full Text] [Related]
20. Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.
Maruyama Y; Lindholm B; Stenvinkel P
J Nephrol; 2004; 17 Suppl 8():S72-6. PubMed ID: 15599890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
